Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.47 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.47 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 2/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.32 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.32 |
| ▸ | VHL | P40337 | 1/20 | 0.31 |
| ▸ | ELOC | Q15369 | 1/20 | 0.31 |
| ▸ | ELOB | Q15370 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2535263 | 0.82 | KIF11 (0.42) | GABRA1GABRG2GABRB3KIF11GABRB2 | |
| SCHEMBL18969110 | 0.80 | KIF11 (0.41) | GABRA1GABRG2GABRB3KIF11PDK2 | |
| SCHEMBL993942 | 0.80 | KIF11 (0.45) | GABRA1GABRG2GABRB3KIF11GABRB2 | |
| SCHEMBL993831 | 0.80 | KIF11 (0.41) | GABRA1GABRG2GABRB3KIF11GABRB2 | |
| SCHEMBL17600535 | 0.79 | KIF11 (0.49) | GABRA1GABRG2GABRB3KIF11GABRB2 | |
| SCHEMBL17600537 | 0.78 | KIF11 (0.41) | GABRA1GABRG2GABRB3KIF11GABRB2 | |
| SCHEMBL31751418 | 0.78 | KIF11 (0.41) | GABRA1GABRG2GABRB3KIF11GABRB2 | |
| Hydrochloric Acid SCHEMBL993872 | 0.78 | KIF11 (0.44) | GABRA1GABRG2GABRB3KIF11ADORA2A | |
| SCHEMBL16050172 | 0.78 | RXRA (0.49) | KIF11TSHRCA2RXRARXRB | |
| SCHEMBL18969775 | 0.77 | KIF11 (0.40) | GABRA1GABRG2GABRB3KIF11PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262615-A1 | ANTIOXIDANTS CONTAINING DIAZIRINE FUNCTIONALITIES, COMPOSITIONS COMPRISING THEM AND USE THEREOF | BELLARE ANUJ (US) | 2025-12-26 | — | — | WO | claimed |
| US-12312741-B2 | Process for dyeing high-performance textiles | US GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2025-05-27 | — | — | US | claimed |
| US-20250066997-A1 | PROCESS FOR DYEING HIGH-PERFORMANCE TEXTILES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2025-02-27 | — | — | US | claimed |
| WO-2026099154-A1 | ADHESIVE DEVICE WITH HIGH BONDING STRENGTH | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| EP-4724416-A2 | MECHANOPHORE CROSSLINKERS FOR TOUGH, CROSSLINKED POLYMERS | Duke University (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4242215-B1 | REACTIVITY-IMPARTING COMPOUND, METHOD FOR PRODUCING REACTIVITY-IMPARTING COMPOUND, AND LAYERED BODY | NATIONAL UNIV CORPORATION IWATE UNIV (JP) | 2026-02-25 | — | — | EP | disclosed |
| WO-2025262615-A1 | ANTIOXIDANTS CONTAINING DIAZIRINE FUNCTIONALITIES, COMPOSITIONS COMPRISING THEM AND USE THEREOF | BELLARE ANUJ (US) | 2025-12-26 | — | — | WO | disclosed |
| US-12312741-B2 | Process for dyeing high-performance textiles | US GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2025-05-27 | — | — | US | disclosed |
| US-20250074929-A1 | REACTIVITY-IMPARTING COMPOUND, METHOD FOR PRODUCING REACTIVITY-IMPARTING COMPOUND, AND LAYERED BODY | NATIONAL UNIVERSITY CORPORATION, IWATE UNIVERSITY (JP) | 2025-03-06 | — | — | US | disclosed |
| US-20250066997-A1 | PROCESS FOR DYEING HIGH-PERFORMANCE TEXTILES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2023195932-A2 | USES OF DIAZIRINES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2023-10-12 | — | — | WO | disclosed |
| US-7713706-B2 | Method of fixing low-molecular compound to solid-phase support | RIKEN (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7713706-B2 | Method of fixing low-molecular compound to solid-phase support | RIKEN (JP) | 2010-05-11 | — | — | US | disclosed |
| WO-2009145816-A2 | NOVEL N-BENZYLAMIDE SUBSTITUTED DERIVATIVES OF 2-(ACYLAMIDO)ACETIC ACID AND 2-(ACYLAMIDO)PROPIONIC ACIDS: POTENT NEUROLOGICAL AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2009-12-03 | — | — | WO | disclosed |
| WO-2009145816-A2 | NOVEL N-BENZYLAMIDE SUBSTITUTED DERIVATIVES OF 2-(ACYLAMIDO)ACETIC ACID AND 2-(ACYLAMIDO)PROPIONIC ACIDS: POTENT NEUROLOGICAL AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2009-12-03 | — | — | WO | disclosed |
| US-20080124809-A1 | Method of Interaction Observation | RIKEN (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20080124809-A1 | Method of Interaction Observation | RIKEN (JP) | 2008-05-29 | — | — | US | disclosed |
| US-20070266775-A1 | Method for producing a biosensor | FUJIFILM CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070266775-A1 | Method for producing a biosensor | FUJIFILM CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| EP-1811301-A1 | METHOD OF INTERACTION OBSERVATION | Riken (JP) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074929-A1 | REACTIVITY-IMPARTING COMPOUND, METHOD FOR PRODUCING REACTIVITY-IMPARTING COMPOUND, AND LAYERED BODY | INSRR, INSR, CYP2E1 | GABRA1 1525/4885GABRG2 3563/4885GABRB3 2817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.